Related Experiment Video

Updated: Jun 5, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Clinical and biochemical consequences of p450 oxidoreductase deficiency

Christa E Flück, Amit V Pandey

    Endocrine Development
    |December 18, 2010
    PubMed

    Insights

    P450 oxidoreductase (POR) deficiency impacts steroidogenesis and drug metabolism, causing adrenal insufficiency, genital anomalies, and skeletal issues. Each POR mutation requires separate study due to varied effects on P450 enzymes.

    Area of Science:

    • Biochemistry
    • Genetics
    • Endocrinology

    Background:

    • P450 oxidoreductase (POR) deficiency is linked to adrenal insufficiency, genital anomalies, and Antley-Bixler craniosynostosis syndrome.
    • Over 40 POR mutations have been identified in more than 65 patients since 2004.
    • POR is essential for all microsomal P450 enzymes, including key steroidogenic enzymes like CYP17A1, CYP21A2, and CYP19A1.

    Purpose of the Study:

    • To investigate the impact of POR deficiency on steroidogenesis, sexual development, and drug metabolism.
    • To analyze the varying effects of different POR mutations on P450 enzyme activities.
    • To highlight the clinical significance of POR variants in patient care.

    Main Methods:

    • Functional assays were employed to assess the effects of POR mutations on steroidogenesis.
    • Analysis of P450 enzyme activities (CYP17A1, CYP21A2, CYP19A1) in the presence of POR variants.
    • Review of clinical presentations and genetic data from patients with POR deficiency.

    Main Results:

    • POR deficiency leads to disordered sexual development, including undervirilization in 46,XY and overvirilization in 46,XX individuals.
    • Impaired aromatization and potential involvement of the 'backdoor' androgen biosynthesis pathway contribute to sexual development abnormalities.
    • Different POR variants exhibit varying degrees of impairment on CYP17A1, CYP21A2, and CYP19A1 activities, necessitating individual assessment.
    • POR variants can also affect skeletal development and the metabolism of drugs processed by hepatic P450 enzymes.

    Conclusions:

    • POR deficiency has multifaceted effects on steroidogenesis, sexual development, skeletal formation, and drug metabolism.
    • Each POR mutation's impact on specific P450 enzymes must be evaluated independently.
    • Understanding POR variants is crucial for managing patients with related endocrine and developmental disorders and for predicting drug responses.

    More Related Videos

    Quantification of Coenzyme A in Cells and Tissues08:51

    Quantification of Coenzyme A in Cells and Tissues

    Published on: September 27, 2019

    Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

    Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

    Published on: October 12, 2017

    Related Concept Videos

    Drug Metabolism: Phase I Reactions01:17

    Drug Metabolism: Phase I Reactions

    A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
    Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

    Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

    Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
    Protein Import into the Peroxisomes01:27

    Protein Import into the Peroxisomes

    Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
    Peroxisomal Protein Import:
    Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
    Phase I Oxidative Reactions: Overview01:19

    Phase I Oxidative Reactions: Overview

    Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
    Peroxisomes01:24

    Peroxisomes

    Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
    Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

    Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

    Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
    Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...